Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Devlin

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Transplantation and Cellular Therapy|December 19, 2024
Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative Care InterventionAbigail G Cohen, Christina Cho, Emily Patterson, et al.
Transplantation and Cellular Therapy|October 8, 2023
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell TherapyMaria-Stefania Infante, David Nemirovsky, Sean Devlin, et al.
Transplantation and Cellular Therapy|October 24, 2024
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective CohortGiovanna Melica, Alejandro Luna de Abia, Gunjan L Shah, et al.
JAMA Oncology|July 19, 2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaOla Landgren, Jonathan N Hofmann, Charlene M McShane, et al.
Blood Advances|October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemiaWarren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.
Blood Advances|October 29, 2024
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomesYannis K Valtis, Sean Devlin, Roni Shouval, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative NeoplasmsRaajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 7, 2018
CD34<sup>+</sup> Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome Pere Barba, Rodrigo Martino, Qin Zhou, et al.
Blood Advances|August 19, 2024
Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicityBrian C Shaffer, Samantha Brown, Stephanie Chinapen, et al.
Blood Advances|December 12, 2018
<i>PHF6</i> and <i>DNMT3A</i> mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiationWenbin Xiao, Maheetha Bharadwaj, Max Levine, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Transplantation and Cellular Therapy|December 19, 2024
Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative Care InterventionAbigail G Cohen, Christina Cho, Emily Patterson, et al.
Transplantation and Cellular Therapy|October 8, 2023
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell TherapyMaria-Stefania Infante, David Nemirovsky, Sean Devlin, et al.
Transplantation and Cellular Therapy|October 24, 2024
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective CohortGiovanna Melica, Alejandro Luna de Abia, Gunjan L Shah, et al.
JAMA Oncology|July 19, 2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaOla Landgren, Jonathan N Hofmann, Charlene M McShane, et al.
Blood Advances|October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemiaWarren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.
Blood Advances|October 29, 2024
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomesYannis K Valtis, Sean Devlin, Roni Shouval, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative NeoplasmsRaajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 7, 2018
CD34<sup>+</sup> Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome Pere Barba, Rodrigo Martino, Qin Zhou, et al.
Blood Advances|August 19, 2024
Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicityBrian C Shaffer, Samantha Brown, Stephanie Chinapen, et al.
Blood Advances|December 12, 2018
<i>PHF6</i> and <i>DNMT3A</i> mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiationWenbin Xiao, Maheetha Bharadwaj, Max Levine, et al.
Pageof 8